Paresh A. Malhotra

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Interpreting evolving evidence in Alzheimer's disease: implications for dementia clinicians.

Interpreting evolving evidence in Alzheimer's disease: implications for dementia clinicians.

Journal: The British journal of psychiatry : the journal of mental science

Published: August 05, 2026

Midlife dementia risk and later dementia-related fear and avoidance: evidence from a prospective cohort study.

Midlife dementia risk and later dementia-related fear and avoidance: evidence from a prospective cohort study.

Journal: Aging & mental health

Published: June 05, 2026

Multi-arm multi-stage platform trials for neurological disease: accelerating progress.

Multi-arm multi-stage platform trials for neurological disease: accelerating progress.

Journal: Lancet (London, England)

Published: May 13, 2026

Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions.

Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions.

Journal: Annals of clinical and translational neurology

Published: April 10, 2026

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 09, 2026

Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's disease.

Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 29, 2026

Cortical synchrony is reduced in Alzheimer's disease and relates to arousal state.

Cortical synchrony is reduced in Alzheimer's disease and relates to arousal state.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 26, 2025

Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer's disease, as part of the Dementias Platform UK.

Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer's disease, as part of the Dementias Platform UK.

Journal: BMJ open

Published: November 21, 2025

The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET.

The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 09, 2025

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 22, 2025

Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing.

Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing.

Journal: F1000Research

Published: August 11, 2025

The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.

The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: July 09, 2025

Showing 1-12 of 109

Last Updated: 09/26/2026